ShareSoc investor presentation

About this update from Inspiration Healthcare Group Plc

  Inspiration Healthcare Group plc ("Inspiration Healthcare", the "Company" or the "Group")   ShareSoc investor presentation   Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company pioneering best-in class, specialist neonatal intensive care medical devices, announces the Company will present at a ShareSoc investor event, in collaboration with Walbrook PR, on Thursday 19, October 2023. The presentation is open to all existing and potential shareholders who are members of ShareSoc.   The presentation will give an update on the Company and the strategic plans going forward over the next 12 months.   All attendees, both in-person and virtual, will have the opportunity to ask questions and those attending the seminar will be able to network with company directors and fellow investors over drinks and a buffet.   To register for the presentation and for further details, please use this link:   ShareSoc & Walbrook PR Healthcare Companies Hybrid Event, London - 19 October 2023, 5pm - ShareSoc No new material information will be disclosed.   For further information, please contact:   Inspiration Healthcare Group plc Tel: +44  (0)330 175 0000   Neil Campbell, Chief Executive Officer Alan Olby, Chief Financial Officer   Walbrook PR Ltd (Media and Investor Relations) Tel: +44 (0)20 7933 8780 or [email protected] Anna Dunphy Mob: +44 (0) 7876 741 001 Stephanie Cuthbert Mob: +44 (0) 7796 794 663 Louis Ashe-Jepson Mob: +44 (0) 7747 515 393     About Inspiration Healthcare   Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in neonatal intensive care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.   The Company has key own brand products that can be used within the first days of life to help premature and sick babies; helping resuscitation and stabilisation in the first moments of life through to preventing brain damage and both invasive and non-invasive respiratory support in terms of capital equipment and disposable medical devices. Additionally, the Company has its own range of products for maintaining normothermia pre, during and post-surgery.   Since September 2019, the Company has acquired Vio Holdings a designer, manufacturer and supplier of single use respiratory products and sterile medical consumables and S.L.E., a leading designer, manufacturer and global provider of neonatal ventilation products.  The Group generates approximately 58% of its revenues from export markets and more than half of its revenues come from its own-branded products.   With product availability actively promoted to over 80 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.   In the UK and Ireland, the Group has direct sales teams selling Group Branded and complementary products from third parties, with an additional range of home healthcare products.  This is supported by Technical Support for planned preventative maintenance and emergency assistance.   The Group operates from various sites in the UK for R&D, Marketing and operations with manufacturing based in Croydon (south London) and Hailsham (East Sussex).  The Group's Head Office is located in Crawley, a short distance from London's Gatwick Airport.   Further information on Inspiration Healthcare can be found at www.inspirationhealthcaregroup.com    

View stock analysis, news, and events for Inspiration Healthcare Group Plc